What is the dosage of Co-amoxiclav (amoxicillin/clavulanic acid) 475mg/5ml syrup for a 3-month-old patient weighing 5.9 kilograms, given 2 times a day for 7 days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-amoxiclav Dosing for a 3-Month-Old Infant

For a 3-month-old infant weighing 5.9 kg requiring co-amoxiclav 475mg/5ml (amoxicillin/clavulanic acid) suspension twice daily, administer 2.5 ml per dose (providing approximately 45 mg/kg/day of amoxicillin component), given every 12 hours for 7 days.

Dosing Calculation and Rationale

Standard Pediatric Dosing

  • The recommended dose of amoxicillin/clavulanic acid for most pediatric infections is 45 mg/kg/day of the amoxicillin component divided into 2 doses 1
  • For this 5.9 kg infant: 45 mg/kg/day × 5.9 kg = 265.5 mg/day total, divided into 2 doses = 132.75 mg per dose
  • Your suspension contains 475 mg amoxicillin per 5 ml, which equals 95 mg/ml
  • To deliver 132.75 mg per dose: 132.75 mg ÷ 95 mg/ml = 1.4 ml per dose

Higher-Dose Considerations

  • For more severe infections or suspected resistant organisms (particularly β-lactamase-producing Haemophilus influenzae or penicillin-resistant Streptococcus pneumoniae), the dose can be increased to 90 mg/kg/day in 2 divided doses 1, 2
  • For this infant at high-dose: 90 mg/kg/day × 5.9 kg = 531 mg/day ÷ 2 = 265.5 mg per dose
  • This equals: 265.5 mg ÷ 95 mg/ml = 2.8 ml per dose

Practical Recommendation

  • Start with 2.5 ml twice daily (approximately 237.5 mg per dose, or ~80 mg/kg/day), which provides adequate coverage for most common pediatric infections while remaining within safe dosing parameters 1
  • This intermediate dose balances efficacy against common pathogens with tolerability 2

Administration Instructions

Timing and Frequency

  • Administer every 12 hours (e.g., 8 AM and 8 PM) to maintain consistent drug levels 1
  • Can be given with or without food, though administration with meals may improve gastrointestinal tolerability 2, 3
  • Complete the full 7-day course even if symptoms improve earlier 1

Preparation and Storage

  • Shake the suspension well before each dose to ensure uniform distribution 3
  • Store reconstituted suspension in refrigerator and discard after 10 days 3
  • Use an oral syringe for accurate measurement rather than household spoons 2

Clinical Monitoring

Expected Response

  • Clinical improvement should be evident within 48-72 hours of initiating therapy 1
  • If the infant's condition deteriorates or shows no improvement within 48-72 hours, further investigation is warranted 1

Common Pitfalls to Avoid

  • Do not underdose: The 475 mg/5ml concentration requires careful calculation to avoid subtherapeutic dosing in small infants 4
  • Do not use adult dosing: Always calculate weight-based dosing for pediatric patients 1
  • Monitor for diarrhea: This is the most common adverse effect, occurring more frequently with three-times-daily dosing than twice-daily regimens 2, 3
  • Watch for hypersensitivity: Skin rash is a common adverse effect; discontinue if severe reaction occurs 5

Infection-Specific Considerations

If Treating Community-Acquired Pneumonia

  • For outpatient CAP in infants >3 months, amoxicillin/clavulanic acid at 90 mg/kg/day in 2 doses is preferred when β-lactamase-producing organisms are suspected 1
  • In this case, use the 2.8 ml per dose calculation above

If Treating Otitis Media or Other Infections

  • Standard dosing of 45 mg/kg/day (1.4 ml per dose) is typically adequate for uncomplicated infections 2
  • High-dose formulations (90 mg/kg/day) are reserved for recurrent or persistent infections after amoxicillin failure 2

Safety Profile

  • Amoxicillin/clavulanic acid is generally well tolerated in infants, with a low incidence of serious adverse events (3.6% in large pediatric studies) 2
  • Gastrointestinal disturbances (nausea, vomiting, diarrhea) are the most frequent side effects but are usually mild 2, 5, 3
  • The clavulanic acid component is more strongly associated with GI side effects and Clostridioides difficile infection risk than amoxicillin alone 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020

Research

Is the standard dose of amoxicillin-clavulanic acid sufficient?

BMC pharmacology & toxicology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.